Liquid Biopsy for Noncoding RNA Improves Cancer Detection
Researchers are developing more accurate and powerful liquid biopsy technologies that take advantage of signals from RNA “dark matter.”
Read More
Search Results for: lung cancer
H. Pylori Infection: Improving Diagnostic Accuracy and Clinical Outcomes
Diagnostic tests for an H. pylori infection can be invasive or noninvasive. Noninvasive testing is more cost-effective.
Read More
Cancer Screenings May Have Saved the U.S. $6.5 Trillion
Americans have gotten at least 12 million more years of life to live due to preventive cancer screenings conducted over the past 25 years.
Read More
Tempus’ Solid Tumor CDx Test Gets Breakthrough Device Designation
The U.S. FDA has granted Tempus Breakthrough Device Designation for its HLA-LOH assay as a companion diagnostic (CDx) test for solid tumors.
Read More
Why Long-Term Smokers May Have a Disease that Defies Diagnosis
Millions of Americans with tobacco-related lung disease have symptoms that do not fit any existing tobacco-related disease criteria.
Read More